Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Masakazu Yasumaru, Masatsugu Hori(Osaka National Hospital), Norio Hayashi(The University of Osaka), Tsutomu Nishida(Toyonaka Municipal Hospital), Yutaka Sasaki(Iwate Medical University), Masahiko Tsujii, Naoki Kawai(Japan Medical Association), Masato Komori(Nagasaki Rousai Hospital), Shingo Tsuji, Takanobu Irie, Hiroaki Murata(University of Nagasaki), Arata Kimura, Sunao Kawano, Yoshimi Kakiuchi(The University of Osaka), Masayoshi Horimoto(The University of Osaka)
PubMed
October 15, 2003
Cited by 70
Related Papers
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573
Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma
|Hepatology|1998|338
Glutaredoxin Exerts an Antiapoptotic Effect by Regulating the Redox State of Akt
|Journal of Biological Chemistry|2003|316
Submucosal tumors: Comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors
|Digestive Endoscopy|2013|278